Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;22(12):65.
doi: 10.1007/s11936-020-00875-1. Epub 2020 Nov 4.

Management and Treatment of Myocarditis in Athletes

Benjamin Hurwitz  1 , Omar Issa  1
Affiliations
Review

Management and Treatment of Myocarditis in Athletes

Benjamin Hurwitz et al. Curr Treat Options Cardiovasc Med. 2020.

Abstract

Purpose of review: Myocarditis is an inflammation of the myocardium that can often be associated with cardiac dysfunction and arrhythmias, and is even one of the leading causes for sudden cardiac death (SCD) in athletes. This review aims to summarize the current evidence and treatment guidelines for the management of myocarditis in the active population.

Recent findings: Physical exertion is likely a trigger for dangerous arrythmias and further propagates myocardial damage in athletes with myocarditis. For this reason, abstinence from sports is a critical facet of management in the initial inflammatory period. The use of cardiac magnetic resonance imaging, specifically late gadolinium enhancement, to guide return to play decisions is becoming more common in clinical practice.

Summary: Establishing a stepwise approach for proper diagnosis and risk stratification, with an emphasis on contemporary cardiac magnetic resonance (CMR) imaging techniques, in myocarditis is critical. After a diagnosis of myocarditis is made, it is imperative for any athlete or highly active individual to refrain from physical exercise. Additionally, therapy for heart failure should be applied in cases of myocarditis with cardiac dysfunction. Undoubtedly, COVID 19, and its potential to cause myocarditis, is sure to change the landscape of management of this disease.

Keywords: Athletes; COVID 19; Cardiomyopathy; Myocarditis; Return to play; Sports eligibility.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestOmar Issa declares that he has no conflict of interest. Benjamin Hurwitz declares that he has no conflict of interest.

Figures

Fig. 1
Fig. 1
Algorithm for an athlete with suspected myocarditis. ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; CK-MB, creatine-kinase MB isoenzyme; BNP, brain natriuretic peptide; EMB, endomyocardial biopsy; LGE, late gadolinium enhancement; ETT, exercise treadmill test; LVEF, left ventricular ejection fraction.
See this image and copyright information in PMC

References

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–48, 2648a-2648d. 10.1093/eurheartj/eht210. - PubMed
    1. Martin SA, Pence BD, Woods JA. Exercise and respiratory tract viral infections. Exerc Sport Sci Rev. 2009;37(4):157–164. doi: 10.1097/JES.0b013e3181b7b57b. - DOI - PMC - PubMed
    1. • Halle M, Binzenhöfer L, Mahrholdt H, Schindler MJ, Esefeld K, Tschöpe C. Myocarditis in athletes: a clinical perspective. Eur J Prev Cardiol. 2020:2047487320909670. 10.1177/2047487320909670. This is a comprehensive review of the identification, diagnosis, and treatment of myocarditis in the modern athlete. The article also highlights the guidelines for sports restriction and return-to-play as indicated by the European Society of Cardiology.
    1. Mahfoud F, Gärtner B, Kindermann M, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 2011;32(7):897–903. doi: 10.1093/eurheartj/ehq493. - DOI - PubMed
    1. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779–792. doi: 10.1016/j.jacc.2011.09.074. - DOI - PubMed